交易 IDEAYA Biosciences, Inc. - IDYA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.12 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
IDEAYA Biosciences Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 17, 2024 | 40.09 | -1.10 | -2.67% | 41.19 | 41.30 | 39.63 |
Apr 16, 2024 | 41.06 | -0.58 | -1.39% | 41.64 | 41.91 | 40.56 |
Apr 15, 2024 | 41.43 | -0.43 | -1.03% | 41.86 | 42.55 | 40.88 |
Apr 12, 2024 | 41.87 | -0.22 | -0.52% | 42.09 | 43.60 | 41.19 |
Apr 11, 2024 | 43.36 | 2.60 | 6.38% | 40.76 | 43.54 | 40.76 |
Apr 10, 2024 | 42.21 | 0.94 | 2.28% | 41.27 | 42.34 | 41.03 |
Apr 9, 2024 | 42.52 | 1.47 | 3.58% | 41.05 | 42.58 | 41.04 |
Apr 8, 2024 | 41.93 | -0.53 | -1.25% | 42.46 | 42.60 | 41.36 |
Apr 5, 2024 | 42.45 | 1.28 | 3.11% | 41.17 | 42.57 | 40.35 |
Apr 4, 2024 | 41.30 | -0.82 | -1.95% | 42.12 | 42.75 | 41.13 |
Apr 3, 2024 | 42.06 | 1.40 | 3.44% | 40.66 | 42.10 | 40.59 |
Apr 2, 2024 | 41.42 | -0.53 | -1.26% | 41.95 | 42.60 | 40.95 |
Apr 1, 2024 | 42.41 | -0.57 | -1.33% | 42.98 | 44.11 | 42.29 |
Mar 28, 2024 | 43.80 | 0.51 | 1.18% | 43.29 | 44.11 | 42.74 |
Mar 27, 2024 | 43.26 | 0.47 | 1.10% | 42.79 | 43.46 | 42.29 |
Mar 26, 2024 | 42.46 | 0.00 | 0.00% | 42.46 | 43.13 | 42.06 |
Mar 25, 2024 | 42.27 | -0.09 | -0.21% | 42.36 | 43.56 | 42.15 |
Mar 22, 2024 | 42.95 | -2.31 | -5.10% | 45.26 | 45.27 | 42.91 |
Mar 21, 2024 | 45.54 | 0.33 | 0.73% | 45.21 | 46.10 | 45.18 |
Mar 20, 2024 | 44.75 | 1.45 | 3.35% | 43.30 | 44.81 | 42.72 |
IDEAYA Biosciences, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, May 7, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 IDEAYA Biosciences Inc Earnings Release Q1 2024 IDEAYA Biosciences Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, June 6, 2024 | ||
時間 (UTC) 19:30 | 國家 US
| 事件 IDEAYA Biosciences Inc Annual Shareholders Meeting IDEAYA Biosciences Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 50.931 | 27.941 | 19.538 | 0 | 0 |
總營業費用 | 113.433 | 78.209 | 54.882 | 44.271 | 36.417 |
銷售/一般/行政費用,總計 | 23.897 | 20.051 | 15.184 | 9.952 | 4.668 |
研究與開發 | 89.536 | 58.158 | 39.698 | 34.319 | 31.749 |
營業收入 | -62.502 | -50.268 | -35.344 | -44.271 | -36.417 |
利息收入(費用),非經營淨值 | 3.847 | 0.506 | 0.849 | 2.288 | 1.994 |
其他,淨值 | 0.008 | 0.077 | |||
稅前淨收入 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
稅後淨收入 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
未計算非常項目前的淨收益 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
淨收入 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
普通股股東可獲收益 (不含非經常性項目) | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
普通股股東可獲收益 (含非經常性項目) | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
攤薄淨收入 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
攤薄後加權平均股 | 41.4447 | 35.2524 | 24.7218 | 12.497 | 19.4786 |
扣除特別項目的每股攤薄盈利 | -1.41526 | -1.41159 | -1.39533 | -3.35882 | -1.76326 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -1.41526 | -1.41159 | -1.39533 | -3.35882 | -1.76326 |
收入 | 50.931 | 27.941 | 19.538 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 3.544 | 7.88 | 4.022 | 29.699 | 5.851 |
收入 | 3.544 | 7.88 | 4.022 | 29.699 | 5.851 |
總營業費用 | 36.253 | 34.159 | 30.465 | 29.039 | 28.35 |
銷售/一般/行政費用,總計 | 7.075 | 6.3 | 5.752 | 6.667 | 5.554 |
研究與開發 | 29.178 | 27.859 | 24.713 | 22.372 | 22.796 |
營業收入 | -32.709 | -26.279 | -26.443 | 0.66 | -22.499 |
利息收入(費用),非經營淨值 | 4.783 | 2.639 | 2.242 | 0.955 | 0.443 |
稅前淨收入 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
稅後淨收入 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
未計算非常項目前的淨收益 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
淨收入 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
普通股股東可獲收益 (不含非經常性項目) | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
普通股股東可獲收益 (含非經常性項目) | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
攤薄淨收入 | -27.926 | -23.64 | -24.201 | 1.615 | -22.056 |
攤薄後加權平均股 | 56.2511 | 48.3701 | 48.2055 | 41.1096 | 38.661 |
扣除特別項目的每股攤薄盈利 | -0.49645 | -0.48873 | -0.50204 | 0.03929 | -0.5705 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.49645 | -0.48873 | -0.50204 | 0.03929 | -0.5705 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 370.454 | 250.996 | 288.605 | 101.654 | 90.667 |
現金和短期投資 | 364.829 | 246.77 | 283.585 | 98.956 | 89.961 |
現金等價物 | 68.632 | 92.046 | 72.037 | 34.067 | 20.505 |
短期投資 | 296.197 | 154.724 | 211.548 | 64.889 | 69.456 |
預付的費用 | 5.414 | 3.123 | 3.143 | 2.698 | 0.706 |
總資産 | 387.969 | 381.347 | 298.269 | 113.001 | 96.541 |
物業/廠房/設備,總計 - 淨額 | 8.993 | 8.661 | 9.476 | 9.699 | 5.152 |
物業/廠房/設備,總計 - 總額 | 16.546 | 14.258 | 13.37 | 12.215 | 6.435 |
累計折舊,總計 | -7.553 | -5.597 | -3.894 | -2.516 | -1.283 |
其他長期資産,總計 | 0.205 | 0.397 | 0.188 | 0.122 | 0.722 |
流動負債總額 | 31.718 | 45.159 | 38.64 | 6.94 | 5.413 |
應付賬款 | 4.28 | 2.1 | 0.953 | 0.709 | 1.417 |
預提費用 | 18.87 | 14.019 | 10.056 | 6.168 | 3.583 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 8.568 | 29.04 | 27.631 | 0.063 | 0.413 |
負債總額 | 38.514 | 79.833 | 99.995 | 12.601 | 7.098 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | 0 | ||||
其他負債,總計 | 6.796 | 34.674 | 61.355 | 5.661 | 1.685 |
股權 | 349.455 | 301.514 | 198.274 | 100.4 | 89.443 |
Redeemable Preferred Stock | 0 | 97.656 | |||
Preferred Stock - Non Redeemable, Net | 0 | 40.735 | |||
普通股 | 0.005 | 0.004 | 0.003 | 0.002 | 0 |
額外實收資本 | 587.724 | 478.97 | 325.25 | 192.824 | 1.599 |
留存收益(累計赤字) | -235.403 | -176.748 | -126.986 | -92.491 | -50.516 |
其他權益,總計 | -2.871 | -0.712 | 0.007 | 0.065 | -0.031 |
總負債和股東權益 | 387.969 | 381.347 | 298.269 | 113.001 | 96.541 |
已發行普通股總數 | 48.1932 | 38.5331 | 29.5372 | 20.3395 | 19.4786 |
長期投資 | 8.317 | 121.293 | 1.526 | ||
應收賬款總額,淨額 | 0.211 | 1.103 | 1.877 | ||
應收賬款 - 貿易,淨額 | 0.211 | 1.103 | 1.877 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 482.182 | 501.788 | 343.958 | 370.454 | 393.437 |
現金和短期投資 | 468.751 | 493.716 | 339.47 | 364.829 | 386.244 |
現金等價物 | 151.85 | 102.843 | 67.237 | 68.632 | 101.954 |
短期投資 | 316.901 | 390.873 | 272.233 | 296.197 | 284.29 |
應收賬款總額,淨額 | 6.703 | 0.16 | 0.468 | 0.211 | 3.449 |
應收賬款 - 貿易,淨額 | 6.703 | 0.16 | 0.468 | 0.211 | 3.449 |
預付的費用 | 6.728 | 7.912 | 4.02 | 5.414 | 3.744 |
總資産 | 532.942 | 527.557 | 364.746 | 387.969 | 410.907 |
物業/廠房/設備,總計 - 淨額 | 7.539 | 8.562 | 8.828 | 8.993 | 9.527 |
物業/廠房/設備,總計 - 總額 | 16.523 | 16.911 | 16.915 | 16.546 | 16.527 |
累計折舊,總計 | -8.984 | -8.349 | -8.087 | -7.553 | -7 |
長期投資 | 42.394 | 16.377 | 11.74 | 8.317 | 7.691 |
其他長期資産,總計 | 0.827 | 0.83 | 0.22 | 0.205 | 0.252 |
流動負債總額 | 24.893 | 25.337 | 29.82 | 31.718 | 32.727 |
應付賬款 | 5.169 | 5.868 | 4.376 | 4.28 | 3.645 |
預提費用 | 18.285 | 16.651 | 19.189 | 18.87 | 18.815 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.439 | 2.818 | 6.255 | 8.568 | 10.267 |
負債總額 | 24.893 | 25.948 | 30.936 | 38.514 | 42.138 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0 | 0.611 | 1.116 | 6.796 | 9.411 |
股權 | 508.049 | 501.609 | 333.81 | 349.455 | 368.769 |
普通股 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 |
額外實收資本 | 823.202 | 789.751 | 594.253 | 587.724 | 583.968 |
留存收益(累計赤字) | -314.409 | -286.969 | -259.043 | -235.403 | -211.202 |
其他權益,總計 | -0.75 | -1.179 | -1.405 | -2.871 | -4.002 |
總負債和股東權益 | 532.942 | 527.557 | 364.746 | 387.969 | 410.907 |
已發行普通股總數 | 58.6264 | 57.4403 | 48.3904 | 48.1932 | 48.0904 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -58.655 | -49.762 | -34.495 | -41.975 | -34.346 |
經營活動産生的現金 | -87.175 | -55.779 | 55.463 | -39.313 | -27.62 |
經營活動産生的現金 | 2.101 | 1.725 | 1.381 | 1.245 | 0.886 |
非現金物品 | 10.934 | 10.071 | 4.171 | 1.701 | 4.186 |
Cash Taxes Paid | 0 | 0.004 | 0.001 | 0.001 | 0.001 |
已付現金利息 | 0.06 | 0.071 | 0.082 | 0.091 | 0.099 |
營運資金的變化 | -41.555 | -17.813 | 84.406 | -0.284 | 1.654 |
投資活動産生的現金 | -33.404 | -69.666 | -146.243 | 2.265 | -63.179 |
資本支出 | -3.443 | -2.644 | -0.493 | -1.353 | -1.708 |
其他投資現金流量項目,總計 | -29.961 | -67.022 | -145.75 | 3.618 | -61.471 |
融資活動産生的現金 | 97.165 | 145.454 | 128.75 | 50.61 | 105.378 |
融資現金流項目 | 0 | 0 | 19.988 | 0 | -0.071 |
股票的發行(報廢),淨額 | 97.165 | 145.454 | 108.762 | 50.61 | 105.449 |
現金淨變化 | -23.414 | 20.009 | 37.97 | 13.562 | 14.579 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -23.64 | -58.655 | -34.454 | -36.069 | -14.013 |
Cash From Operating Activities | -27.842 | -87.175 | -63.805 | -39.639 | -19.647 |
Cash From Operating Activities | 0.588 | 2.101 | 1.543 | 0.974 | 0.464 |
Non-Cash Items | 2.102 | 10.934 | 9.086 | 6.167 | 2.954 |
Cash Taxes Paid | 0 | 0 | 0 | ||
Cash Interest Paid | 0.013 | 0.06 | 0.046 | 0.032 | 0.016 |
Changes in Working Capital | -6.892 | -41.555 | -39.98 | -10.711 | -9.052 |
Cash From Investing Activities | 23.521 | -33.404 | -23.128 | -4.445 | -17.761 |
Capital Expenditures | -0.043 | -3.443 | -3.443 | -2.342 | -0.401 |
Other Investing Cash Flow Items, Total | 23.564 | -29.961 | -19.685 | -2.103 | -17.36 |
Cash From Financing Activities | 2.926 | 97.165 | 96.841 | 1.144 | 0.653 |
Issuance (Retirement) of Stock, Net | 2.926 | 97.165 | 96.841 | 1.144 | 0.653 |
Net Change in Cash | -1.395 | -23.414 | 9.908 | -42.94 | -36.755 |
Financing Cash Flow Items | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
7000 Shoreline Ct Ste 350
SOUTH SAN FRANCISCO
CALIFORNIA 94080-7604
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易